1. Immunohistochemical Characterisation of GLUT1, MMP3 and NRF2 in Osteosarcoma
   Catrin S. Rutland et al, 2021, Frontiers in Veterinary Science CrossRef
2. Glucose transporters as markers of diagnosis and prognosis in cancer diseases
   Leszek Szablewski, 2022, Oncology Reviews CrossRef
3. Relevance of Sugar Transport across the Cell Membrane
   Roxana Carbó et al, 2023, International Journal of Molecular Sciences CrossRef
4. Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma
   Fangyu An et al, 2024, Journal of Bone Oncology CrossRef
5. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
   Chao Ma et al, 2019, Molecular Medicine Reports CrossRef
6. Metabolic reprogramming in osteosarcoma
   Yulu Shi et al, 2023, Pediatric Discovery CrossRef
7. Uptake of fluorescent d- and l-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner
   Tetsuya Ogawa et al, 2021, Human Cell CrossRef
8. Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective
   Mariarita Romanucci et al, 2023, Frontiers in Veterinary Science CrossRef
9. Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients
   Prema Robinson et al, 2023, Journal of Clinical Medicine CrossRef
10. The roles of glycolysis in osteosarcoma
    Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
11. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma
    C. Gola et al, 2020, The Veterinary Journal CrossRef